Log in to save to my catalogue

Plasma p-tau and neurofilament/p-tau ratio in differentiating Alzheimer's disease from syndromes ass...

Plasma p-tau and neurofilament/p-tau ratio in differentiating Alzheimer's disease from syndromes ass...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_346996

Plasma p-tau and neurofilament/p-tau ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration

About this item

Full title

Plasma p-tau and neurofilament/p-tau ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration

Journal title

Alzheimer's & dementia, 2025

Language

English

Formats

More information

Scope and Contents

Contents

INTRODUCTION: Plasma-based biomarkers have shown promise for clinical implementation, but their accuracy in differentiating Alzheimer's disease (AD) from syndromes associated with frontotemporal lobar degeneration (FTLD) has yet to be fully investigated. This study assessed the potential of plasma biomarkers for differential diagnosis. METHODS: Thi...

Alternative Titles

Full title

Plasma p-tau and neurofilament/p-tau ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_346996

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_346996

Other Identifiers

ISSN

1552-5260,1552-5279

DOI

10.1002/alz.14482

How to access this item